A new study reveals manufacturers often submit medical device adverse event reports late. Also, senators are questioning telehealth platforms’ ties to pharmaceutical companies, and Hinge Health plans its IPO.
A recap of significant developments in health technology, including late FDA reports on adverse events, senators questioning telehealth-pharma ties, a look at Hinge Health’s IPO plans, and Apple’s Parkinson’s tech.
